Clinical Trials
17 trialsNCT07404527 2026-02-13
Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT01326468 2025-09-25
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
Thomas Jefferson University
Phase NA Withdrawn
NCT00502463 2024-02-07
ASOG-HNO1
Austrian South Oncology Group
Phase NA Completed
NCT02324608 2023-12-20
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Rutgers, The State University of New Jersey
Phase NA Completed
NCT06035133 2023-09-13
Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy
Tang-Du Hospital
Phase NA Not yet recruiting
NCT05873972 2023-05-24
Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient
Fudan University
Phase NA Unknown
NCT02177838 2021-04-21
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Rutgers, The State University of New Jersey
Phase NA Terminated
NCT01280643 2021-03-15
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT01663259 2021-01-19
Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT01317433 2020-03-25
SKINUX
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT02241187 2017-09-27
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01834014 2017-08-02
ATOM ES
EPS Corporation
Phase NA Completed
NCT00448838 2016-12-15
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
University of Miami
Phase NA Completed
NCT00891904 2016-04-14
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Phase NA Terminated
NCT00084773 2015-12-22
Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01631539 2014-12-04
Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
Universitaire Ziekenhuizen KU Leuven
Phase NA Withdrawn
NCT01790516 2014-10-02
Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
Georgetown University
Phase NA Terminated